The level of evidence for permitting a qualified health claim: FDA's review of the evidence for selenium and cancer and vitamin E and heart disease

J Nutr. 2005 Feb;135(2):354-6. doi: 10.1093/jn/135.2.354.

Abstract

Health claims are authorized for the labeling of foods when there is significant scientific agreement among qualified experts on the evidence for a relationship between a food or food component (substance) and a disease. Qualified health claims are permitted when there is less scientific evidence for a substance-disease relationship, therefore requiring qualifying language. The evidence for a relationship between vitamin E and heart disease and selenium and cancer was reviewed by the U.S. FDA. It was determined that there was insufficient evidence to permit a qualified health claim for vitamin E and cancer, whereas there was some evidence for permitting a qualified health claim for selenium and cancer. The rationale for these conclusions is discussed below.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cardiovascular Diseases / prevention & control
  • Heart Diseases / prevention & control*
  • Neoplasms / prevention & control*
  • Reproducibility of Results
  • Selenium*
  • United States
  • United States Food and Drug Administration
  • Vitamin E*

Substances

  • Vitamin E
  • Selenium